Skip to main content

Coronary Circulation and Myocardial Ischaemia: Thrombolysis

  • Chapter
Coronary Circulation and Myocardial Ischemia

Part of the book series: Update in Intensive Care Medicine ((UICMSOFT,volume 32))

  • 94 Accesses

Abstract

The past 1–2 decades have seen a revolution in the treatment of myocardial infarction (MI), so that the case fatality of those who reach hospital has about halved [1]. This improvement has been related to several factors, but mainly to the timely dissolution of the culprit thrombus by thrombolytic drugs [2] or later by direct PTCA [3], and the enhancement of this process by inhibition of platelet aggregation by aspirin [4] and the newer more powerful IIb/IIIa receptor antagonists.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Volmink JA Newton JN, Hicks NR, Sleight P, Fowler GH, Neil HAW, on behalf of the Oxford Myocardial Infarction Incidence Study Group (1998). Coronary event and case fatality rates in an English population: result s of the Oxford Myocardial Infarction Incidence Study (OXMIS). Heart 80: 40–44

    PubMed  CAS  Google Scholar 

  2. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group (1994). Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343: 311–322

    Google Scholar 

  3. Grines CL, O’Neill WW. Primary angioplasty (1995). Br Heart J 73: 405–406

    Article  PubMed  CAS  Google Scholar 

  4. Sleight P (Chairman) ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349–60

    Google Scholar 

  5. Collins R, MacMahon S, Flather M, Baigent C, Remvig L, Mortensen S, Appleby P, Godwin J, Yusuf S, Peto R. Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ 1996; 313: 652–659

    Article  PubMed  CAS  Google Scholar 

  6. Simoons ML, de Boer MJ, van den Brand MJBM, van Miltenburg AJM, Hoorntje JCA, Heyndrickx GR, van der Wieken LR, et al. and the European Cooperative Study Group (1994). Randomized trial of a GPIIb IIIa platelet receptor blocker in refractory unstable angina. Circulation 89:596–603

    PubMed  CAS  Google Scholar 

  7. Hackett D, Davies G, Chierchia S, Maseri A (1987). Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med 317: 1055–1059

    Article  PubMed  CAS  Google Scholar 

  8. Chambless L, Keil U, Dobson A, et al. for the WHO MONICA project (1997). Population versus clinical view of case fatality from acute coronary heart disease. Results from the WHO MONICA Project 1985–1990. Circulation 96: 3849–3859

    PubMed  CAS  Google Scholar 

  9. Boersma E, Maas AC, Deckers JW, Simoons ML(1996). Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 348: 771–775

    Article  PubMed  CAS  Google Scholar 

  10. Collins R, Peto R, Baigent C, Sleight P (1997). Aspirin, heparin and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 336: 847–860

    Article  PubMed  CAS  Google Scholar 

  11. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators (1997). A clinical trial comparing primary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 336: 1621–1628

    Article  Google Scholar 

  12. Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the Elderly? (1991) JAMA 265: 1720–1723

    Article  PubMed  CAS  Google Scholar 

  13. Pashos CL, Normand S-LT, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ. (1994) Trends in the use of drug therapies in patients with acute myocardial infarction: 1988–1992. JACC 23: 1023–1030

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sleight, P. (2002). Coronary Circulation and Myocardial Ischaemia: Thrombolysis. In: Pinsky, M.R., Artigas, A., Dhainaut, JF. (eds) Coronary Circulation and Myocardial Ischemia. Update in Intensive Care Medicine, vol 32. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57212-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57212-8_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42588-5

  • Online ISBN: 978-3-642-57212-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics